May 2024
1. MAKHNEVICH A, Perrin A, Talukder D, Liu Y, et al
   Thick Liquids and Clinical Outcomes in Hospitalized Patients With Alzheimer Disease and Related Dementias and Dysphagia.
   JAMA Intern Med. 2024 May 6:e240736. doi: 10.1001/jamainternmed.2024.0736.
   

   >> Share

   
   
2. REUBEN DB, Kremen S, Maust DT
   Dementia Prevention and Treatment: A Narrative Review.
   JAMA Intern Med. 2024;184:563-572.
   

   >> Share

   
   October 2023
3. BRENDER TD
   Chatbot Confabulations Are Not Hallucinations-Reply.
   JAMA Intern Med. 2023;183:1177-1178.
   

   >> Share

   
   July 2023
4. MOLCHAN S, Fugh-Berman A
   Are New Alzheimer Drugs Better Than Older Drugs?
   JAMA Intern Med. 2023 Jul 31. doi: 10.1001/jamainternmed.2023.3061.
   

   >> Share

   
   June 2022
5. WOLOSHIN S, Kesselheim AS
   What to Know About the Alzheimer Drug Aducanumab (Aduhelm).
   JAMA Intern Med. 2022 Jun 6. pii: 2792897. doi: 10.1001/jamainternmed.2022.1039.
   

   >> Share

   
   March 2022
6. PALAN LOPEZ R, Hendricksen M, McCarthy EP, Mazor KM, et al
   Association of Nursing Home Organizational Culture and Staff Perspectives With Variability in Advanced Dementia Care: The ADVANCE Study.
   JAMA Intern Med. 2022;182:313-323.
   

   >> Share

   
   February 2022
7. LEE CS, Gibbons LE, Lee AY, Yanagihara RT, et al
   Association Between Cataract Extraction and Development of Dementia.
   JAMA Intern Med. 2022;182:134-141.
   

   >> Share

   
   December 2021
8. LARGENT EA, Peterson A, Lynch HF
   FDA Drug Approval and the Ethics of Desperation.
   JAMA Intern Med. 2021;181:1555-1556.
   

   >> Share

   
   October 2021
9. CROSSON FJ, Covinsky K, Redberg RF
   Medicare and the Shocking US Food and Drug Administration Approval of Aducanumab: Crisis or Opportunity?
   JAMA Intern Med. 2021;181:1278-1280.
   

   >> Share

   
   July 2021
10. STEINBROOK R
    The Accelerated Approval of Aducanumab for Treatment of Patients With Alzheimer Disease.
    JAMA Intern Med. 2021 Jul 13. pii: 2782122. doi: 10.1001/jamainternmed.2021.4622
    

    >> Share

    
    
11. DUNN B, Stein P, Cavazzoni P
    Approval of Aducanumab for Alzheimer Disease-the FDA's Perspective.
    JAMA Intern Med. 2021 Jul 13. pii: 2782119. doi: 10.1001/jamainternmed.2021.4607
    

    >> Share

    
    
12. MITCHELL SL, D'Agata EMC, Hanson LC, Loizeau AJ, et al
    The Trial to Reduce Antimicrobial Use in Nursing Home Residents With Alzheimer Disease and Other Dementias (TRAIN-AD): A Cluster Randomized Clinical Trial.
    JAMA Intern Med. 2021 Jul 12. pii: 2782003. doi: 10.1001/jamainternmed.2021.3098
    

    >> Share

    
    November 2020
13. NICHOLAS LH, Langa KM, Bynum JPW, Hsu JW, et al
    Financial Presentation of Alzheimer Disease and Related Dementias.
    JAMA Intern Med. 2020 Nov 30. pii: 2773241. doi: 10.1001/jamainternmed.2020.6432
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share